Company / Cost of Revenue
Charles River Laboratories Cost of Revenue History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$289.7M
FY2017
5-year range
-
FY2016-FY2017
Trend
+4.6%
vs FY2016
Sector context
#77 of 113
Health Care
What the data says
At $290M, Charles River Laboratories's cost of revenue ranks #37 of 113 in the Health Care sector.
Based on SEC 10-K filings.
$290M in FY2017.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#37 of 113 in Health CareTop 32% of 113This company $289.7M Sector average $11.3B
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2017, cost of revenue increased 4.6% year-over-year.
- Ranks #77 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $289.7M | +4.6% |
| FY2016 | $277.0M | +1.6% |
As of FY2017 · SEC 10-K · Updated Jul 4, 2026